Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
| ▸ | CTSD | P07339 | 5/20 | 0.42 |
| ▸ | MMP1 | P03956 | 2/20 | 0.41 |
| ▸ | MME | P08473 | 8/20 | 0.39 |
| ▸ | ACE | P12821 | 8/20 | 0.39 |
| ▸ | CPA1 | P15085 | 8/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 8/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GRB2 | P62993 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29468879 | 0.95 | ABCB1 (0.41) | ABCB1CTSDMMP1MMEACE | |
| SCHEMBL30422538 | 0.93 | CTSD (0.44) | ABCB1CTSDMMP1MMEACE | |
| SCHEMBL30422599 | 0.93 | CTSD (0.44) | ABCB1CTSDMMP1MMEACE | |
| SCHEMBL30422261 | 0.91 | CTSD (0.43) | ABCB1CTSDMMP1GRB2 | |
| SCHEMBL29468853 | 0.90 | GRB2 (0.43) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL29468876 | 0.89 | CTSD (0.41) | ABCB1CTSDMMP1MMEACE | |
| SCHEMBL30422838 | 0.87 | CTSD (0.42) | ABCB1CTSDMMP1GRB2PTPN1 | |
| SCHEMBL30852859 | 0.84 | ABCB1 (0.43) | ABCB1MMP1 | |
| SCHEMBL29631187 | 0.82 | ABCB1 (0.48) | ABCB1CTSDMMP1MMEACE | |
| SCHEMBL30863604 | 0.81 | ACACB (0.43) | CTSDACEGRB2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724471-A1 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252366-A1 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-12-12 | — | — | WO | disclosed |
| EP-4204440-A1 | GLP-1/GIP DUAL AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2023-07-05 | — | — | EP | disclosed |
| WO-2022079639-A1 | GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2022-04-21 | — | — | WO | disclosed |